Yuji Tajiri Selected Research

Yuji Tajiri Research Topics

Disease

12	Type 2 Diabetes Mellitus (MODY) 01/2022 - 10/2005
9	Insulin Resistance 07/2020 - 10/2007
6	Diabetes Mellitus 07/2020 - 09/2009
3	Body Weight (Weight, Body) 01/2022 - 01/2014
3	Hyperglycemia 11/2019 - 04/2012
3	Weight Loss (Weight Reduction) 11/2019 - 09/2015
3	Hypoglycemia (Reactive Hypoglycemia) 01/2018 - 01/2014
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2013 - 12/2010
3	Inflammation (Inflammations) 01/2013 - 10/2005
3	Atherosclerosis 04/2010 - 10/2005
2	Obesity 01/2020 - 01/2013
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2013 - 10/2005
1	Sarcopenia 01/2022
1	Polydipsia 11/2019
1	Thyroid Diseases (Thyroid Disease) 11/2019
1	Hashimoto Disease (Thyroiditis, Hashimoto) 11/2019
1	Polyuria 11/2019
1	Myasthenia Gravis 11/2019
1	Lipodystrophy 11/2019
1	Prolactinoma (Prolactinomas) 11/2019
1	Hypertriglyceridemia 11/2019
1	Glucose Intolerance 11/2019
1	Dyslipidemias (Dyslipidemia) 11/2019
1	Congenital Generalized Lipodystrophy (Berardinelli-Seip Congenital Lipodystrophy) 11/2019
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2019
1	Fibrosis (Cirrhosis) 01/2018
1	Non-alcoholic Fatty Liver Disease 01/2018
1	Pleural Effusion (Pleural Effusions) 07/2016
1	Lung Neoplasms (Lung Cancer) 07/2016
1	Pleurisy (Pleuritis) 07/2016
1	Starvation 01/2015
1	Ketosis 01/2015
1	Anterograde Amnesia 01/2013
1	Parasomnias (Parasomnia) 01/2013
1	Hyperphagia (Overeating) 04/2012
1	Weight Gain 01/2012
1	Chronic Kidney Failure (Chronic Renal Failure) 10/2010
1	Hypothyroidism 01/2010
1	Hyperthyroidism 01/2010
1	Thyrotoxicosis 01/2010

Drug/Important Bio-Agent (IBA)

12	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 12/2010
7	Insulin (Novolin)FDA Link 07/2020 - 04/2011
4	Hypoglycemic Agents (Hypoglycemics)IBA 01/2022 - 01/2013
3	GhrelinIBA 01/2020 - 04/2012
3	AdiponectinIBA 11/2019 - 01/2013
3	Sitagliptin Phosphate (Januvia)FDA Link 11/2017 - 01/2012
3	C-Reactive ProteinIBA 09/2009 - 10/2005
2	SymportersIBA 01/2022 - 07/2020
2	SodiumIBA 01/2022 - 07/2020
2	Blood Glucose (Blood Sugar)IBA 01/2022 - 11/2019
2	C-PeptideIBA 11/2019 - 09/2009
2	Dipeptidyl-Peptidase IV InhibitorsIBA 11/2017 - 01/2014
2	KetonesIBA 11/2015 - 01/2015
1	Sodium-Glucose Transporter 2 InhibitorsIBA 07/2020
1	Hormones (Hormone)IBA 01/2020
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 11/2019
1	HLA-DR9 antigenIBA 11/2019
1	HLA Antigens (Human Leukocyte Antigens)IBA 11/2019
1	Iodide Peroxidase (Deiodinase)IBA 11/2019
1	LipidsIBA 11/2019
1	metreleptinIBA 11/2019
1	Bromocriptine (Parlodel)FDA LinkGeneric 11/2019
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 11/2019
1	Lipoproteins (Lipoprotein)IBA 11/2019
1	VLDL CholesterolIBA 11/2019
1	LeptinIBA 11/2019
1	CytokinesIBA 01/2018
1	SterolsIBA 01/2018
1	ElementsIBA 01/2018
1	SecretagoguesIBA 01/2018
1	LinagliptinIBA 11/2017
1	Metformin (Glucophage)FDA LinkGeneric 01/2017
1	Talc FDA Link 07/2016
1	ipragliflozinIBA 11/2015
1	Insulin SecretagoguesIBA 01/2015
1	Ketone BodiesIBA 01/2015
1	Hemoglobins (Hemoglobin)IBA 01/2014
1	Hypnotics and Sedatives (Sedatives)IBA 01/2013
1	AntibodiesIBA 02/2011
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 02/2011
1	InterferonsIBA 02/2011
1	Ribavirin (Virazole)FDA LinkGeneric 02/2011
1	Insulin Glargine (Lantus)FDA Link 12/2010
1	Glycated Serum AlbuminIBA 10/2010
1	HDL CholesterolIBA 04/2010
1	Triglycerides (Triacylglycerol)IBA 04/2010
1	Thyroglobulin FDA Link 01/2010
1	Sunitinib (Sutent)FDA Link 01/2010
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2010
1	Tyrosine Kinase InhibitorsIBA 01/2010
1	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2010

Therapy/Procedure

4	Therapeutics 11/2019 - 01/2010
2	Glycemic Control 01/2012 - 10/2007
2	Cardiopulmonary Resuscitation (CPR) 09/2009 - 10/2007
1	Aftercare (After-Treatment) 07/2020
1	Drug Therapy (Chemotherapy) 11/2019
1	Hematopoietic Stem Cell Transplantation 11/2019
1	Stem Cell Transplantation 11/2019
1	Injections 01/2018
1	Pleurodesis 07/2016